Targeting the DNA Damage Response for Anti-Cancer Therapy - Bog - Paperback

Targeting the DNA Damage Response for Anti-Cancer Therapy

As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents that may have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.